Description
VRK-IN-1 is a potent and selective inhibitor of vaccinia-related kinases 1 (VRK1), with an IC50 of 150 nM. VRK1 is human Ser/Thr protein kinases associated with increased cell division and neurological disorders.
Product information
CAS Number: 2378855-09-3
Molecular Weight: 349.28
Formula: C18H11F4NO2
Chemical Name: 4-[5-(3,5-difluoro-4-hydroxyphenyl)-2-methylpyridin-3-yl]-2,6-difluorophenol
Smiles: CC1=NC=C(C=C1C1=CC(F)=C(O)C(F)=C1)C1C=C(F)C(O)=C(F)C=1
InChiKey: PMRGRXLXKYUDIH-UHFFFAOYSA-N
InChi: InChI=1S/C18H11F4NO2/c1-8-12(10-5-15(21)18(25)16(22)6-10)2-11(7-23-8)9-3-13(19)17(24)14(20)4-9/h2-7,24-25H,1H3
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
How to use
In Vitro:
VRK-IN-1 binds to VRK1-FL by enthalpy-driven, with a Kd of 190 nM. VRK-IN-1 (0.4-25 μM; 24 h) slightly decreases the viability of human HeLa cells at the concentration of 3.2 μM.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.